Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Biolife Solutions Inc shares valued at $15,857 were sold by Mathew Aby J. on Dec 09 ’25. At $25.13 per share, Mathew Aby J. sold 631 shares. The insider’s holdings dropped to 349,755 shares worth approximately $8.46 million following the completion of this transaction.
Also, Wichterman Troy sold 1,033 shares, netting a total of over 25,959 in proceeds. Following the sale of shares at $25.13 each, the insider now holds 151,736 shares.
Before that, Aebersold Sarah had sold 713 shares from its account. In a trade valued at $17,440, the Chief Human Resources Officer traded Biolife Solutions Inc shares for $24.46 each. Upon closing the transaction, the insider’s holdings decreased to 713 shares, worth approximately $1.84 million.
Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late September. As of April 04, 2024, Jefferies has initiated its “Buy” rating for BLFS. Earlier on July 11, 2023, Craig Hallum initiated its rating. Their recommendation was “a Buy” for BLFS stock.
Analyzing BLFS Stock Performance
On last trading session, Biolife Solutions Inc [NASDAQ: BLFS] plunged -1.95% to $24.18. The stock’s lowest price that day was $24.01, but it reached a high of $24.71 in the same session. During the last five days, there has been a drop of approximately -5.03%. Over the course of the year, Biolife Solutions Inc shares have dropped approximately -9.06%. Shares of the company reached a 52-week high of $29.62 on 10/24/25 and a 52-week low of $19.10 on 04/09/25.
Support And Resistance Levels for Biolife Solutions Inc (BLFS)
According to the 24-hour chart, there is a support level at 23.89, which, if violated, would cause prices to drop to 23.60. In the upper region, resistance lies at 24.59. The next price resistance is at 25.00. RSI (Relative Strength Index) is 38.43 on the 14-day chart, showing neutral technical sentiment.
Is Biolife Solutions Inc subject to short interest?
Stocks of Biolife Solutions Inc saw a sharp steep in short interest on 2025-12-15 dropping by -0.16 million shares to 2.78 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 2.94 million shares. A decline of -5.86% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.01 of the overall float, the days-to-cover ratio (short ratio) decline to 8.01.
Which companies own the most shares of Biolife Solutions Inc (BLFS)?
In terms of Biolife Solutions Inc share price expectations, FactSet research, analysts set an average price target of 32 in the next 12 months, up nearly 29.76% from the previous closing price of $24.66. Analysts anticipate Biolife Solutions Inc stock to reach 32 by 2026, with the lowest price target being 32. In spite of this, 4 analysts ranked Biolife Solutions Inc stock as Buy at the end of 2026. On April 25, 2022, Oppenheimer assigned a price target of “an Outperform” to the stock and upgraded coverage with a $28.
